Christopher R. Chapple, Gerard Amarenco, Miguel A. López Aramburu, Karel Everaert, Josef Liehne, Malcolm Lucas, Viktor Vik, Arwin Ridder, Robert Snijder, Osamu Yamaguchi and on behalf of the BLOSSOM Investigator Group A proof-of-concept study: Mirabegron, a new therapy for overactive bladder Neurourology and Urodynamics 32
Article first published online: 19 FEB 2013 | DOI: 10.1002/nau.22373
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.